Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Although the incidence and prevalence of irAEs have been well characterized in the literature, less is known about the cumulative incidence rate of irAEs. We studied the cumulative incidence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuzzo, Pier Vitale, Pond, Gregory R, Abou Alaiwi, Sarah, Nassar, Amin H, Flippot, Ronan, Curran, Catherine, Kilbridge, Kerry L, Wei, Xiao X, McGregor, Bradley A, Choueiri, Toni, Harshman, Lauren C, Sonpavde, Guru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174062/
https://www.ncbi.nlm.nih.gov/pubmed/32234849
http://dx.doi.org/10.1136/jitc-2019-000371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174062/
https://www.ncbi.nlm.nih.gov/pubmed/32234849
http://dx.doi.org/10.1136/jitc-2019-000371

Ejemplares similares